List of Excipients in API acyclovir and hydrocortisone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing acyclovir and hydrocortisone
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Bausch Health US LLC | XERESE | acyclovir and hydrocortisone | 0187-5104 | CETOSTEARYL ALCOHOL | 1969-12-31 |
| Bausch Health US LLC | XERESE | acyclovir and hydrocortisone | 0187-5104 | CITRIC ACID MONOHYDRATE | 1969-12-31 |
| Bausch Health US LLC | XERESE | acyclovir and hydrocortisone | 0187-5104 | HYDROCHLORIC ACID | 1969-12-31 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for acyclovir and hydrocortisone
Excipient focus: CETOSTEARYL ALCOHOL
acyclovir and hydrocortisone drug variants containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
acyclovir and hydrocortisone drug variants not containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
acyclovir and hydrocortisone drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
acyclovir and hydrocortisone drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
acyclovir and hydrocortisone drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
acyclovir and hydrocortisone drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL MYRISTATE
acyclovir and hydrocortisone drug variants containing ISOPROPYL MYRISTATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
acyclovir and hydrocortisone drug variants not containing ISOPROPYL MYRISTATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MINERAL OIL
acyclovir and hydrocortisone drug variants containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
acyclovir and hydrocortisone drug variants not containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PETROLATUM
acyclovir and hydrocortisone drug variants containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
acyclovir and hydrocortisone drug variants not containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
acyclovir and hydrocortisone drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
acyclovir and hydrocortisone drug variants not containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
acyclovir and hydrocortisone drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
acyclovir and hydrocortisone drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
acyclovir and hydrocortisone drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
acyclovir and hydrocortisone drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
acyclovir and hydrocortisone drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
acyclovir and hydrocortisone drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
acyclovir and hydrocortisone drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
acyclovir and hydrocortisone drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch